RANDOMIZED, DOUBLE-BLIND PLACEBO CONTROLLED MULTIPLE DOSE--XOMA

Project: Research project

Project Details

Description

Xoma Zyme CD5 plus is an immunoconjugate comprised of a murine monoclonal antibody present on the majority of human peripheral blood T cells which has been linked to ricin A chain.
StatusFinished
Effective start/end date10/1/899/30/94

Funding

  • National Center for Research Resources

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.